May 9, 2022Quantitative in vitro to in vivo extrapolation for developmental toxicity potency of valproic acid analogues [Birth Defects Research, May 2022]
April 29, 2022microRNAs signatures as potential biomarkers of structural cardiotoxicity in human-induced pluripotent stem-cell derived cardiomyocytes [Organ Toxicity and Mechanisms, April 2022]
February 16, 2022Use of human induced pluripotent stem cell-derived cardiomyocytes to predict the cardiotoxicity potential of Next Generation Nicotine Products [Frontiers in Toxicology, February 2022]
November 15, 2020The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes [Current Research in Toxicology, November 2020]
April 1, 2020Profiling the ToxCast library with a pluripotent human (H9) stem cell line-based biomarker assay for developmental toxicity [Toxicological Sciences, April 2020]
April 1, 2020A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential [Toxicological Sciences, April 2020]
October 16, 2017A Human Induced Pluripotent Stem Cell-Based In Vitro Assay Predicts Developmental Toxicity Through a Retinoic Acid Receptor-Mediated Pathway for a Series of Related Retinoid Analogues [Reproductive Toxicology, 2017]
June 16, 2015Stem Cell-Based Methods for Identifying Developmental Toxicity Potential [Predictive Toxicology, 2015]
August 1, 2013Establishment and Assessment of a New Human Embryonic Stem Cell-Based Biomarker Assay for Developmental Toxicity Screening [Birth Defects Research, 2013]
November 15, 2011Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics
August 15, 2010Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics